UK markets closed

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.99-0.02 (-0.12%)
At close: 04:00PM EDT
15.99 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7776
Avg. Estimate-1.28-1.26-5.08-2.33
Low estimate-1.41-1.43-5.61-5.49
High estimate-1.11-0.94-4.460.12
Year ago EPS-1.66-1.41-6.02-5.08
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6688
Avg. Estimate24.85M26.68M108.73M288.31M
Low estimate15.5M16M63.62M80.61M
High estimate34.7M34.7M158.27M431M
Year ago salesN/AN/A90.24M108.73M
Sales growth (year/est)N/AN/A20.50%165.20%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.38-1.52-1.27-1.26
Actual EPS-1.66-1.41-1.43-1.38
Difference-0.280.11-0.16-0.12
Surprise %-20.30%7.20%-12.60%-9.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.28-1.26-5.08-2.33
7 days ago-1.26-1.23-5.03-2.34
30 days ago-1.22-1.17-4.53-2.19
60 days ago-1.22-1.17-4.53-2.19
90 days ago-1.09-0.97-3.41-2.46
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A12
Up last 30 days2113
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2221
Growth estimatesRGNXIndustrySector(s)S&P 500
Current qtr.22.90%N/AN/AN/A
Next qtr.10.60%N/AN/AN/A
Current year15.60%N/AN/AN/A
Next year54.10%N/AN/AN/A
Next 5 years (per annum)13.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A